AOD-9604 vs Tirzepatide: Research Peptide vs FDA-Approved GLP-1
Verdict Summary
Tirzepatide has robust clinical trial data and FDA approval. AOD-9604 has limited human data and failed its FDA approval process. For clinically validated fat loss, tirzepatide is the evidence-based choice.
Medical Disclaimer: This comparison is for educational purposes only. Consult a healthcare provider before starting any peptide protocol. Full disclaimer →
At a Glance
| Dimension | AOD-9604 | Tirzepatide |
|---|---|---|
| FDA Status | Not approved (failed Phase 3) | Approved (2022) |
| Clinical Evidence | Limited human data | Extensive (SURMOUNT trials) |
| Mechanism | HGH fragment, lipolysis stimulation | GIP + GLP-1 dual agonist |
| Avg. Weight Loss | Modest in trials | ~20-22% |
AOD-9604 Deep Dive
AOD-9604 is a fragment of human growth hormone (hGH176-191) that was studied for fat loss. Despite promising preclinical data, it failed to demonstrate significant weight loss in Phase 3 trials and did not receive FDA approval.
How to Choose
Choose AOD-9604 if…
- •You are a researcher interested in GH-fragment mechanisms
- •You want a research compound with a different mechanism
- •You are exploring alternatives to GLP-1 agonists
Choose Tirzepatide if…
- •Clinically validated, significant weight loss is the goal
- •FDA-approved treatment is required
- •You want the most evidence-based option
Frequently Asked Questions
More Comparisons
BPC-157 vs TB-500
BPC-157 excels at localized tendon, ligament, and gut healing. TB-500 is better for systemic muscle recovery and widespread inflammation.
Semaglutide vs Tirzepatide
Tirzepatide produces greater average weight loss in clinical trials. Semaglutide has a longer post-market safety record. Both are excellent options.
Ipamorelin vs CJC-1295
Ipamorelin and CJC-1295 work through complementary mechanisms and are almost always used together rather than as alternatives.
Ozempic vs Wegovy
Ozempic and Wegovy both contain Semaglutide. The difference is FDA indication and maximum dose — Wegovy is approved for weight management at higher doses.
Mounjaro vs Zepbound
Mounjaro and Zepbound both contain Tirzepatide. Mounjaro is approved for Type 2 diabetes; Zepbound for obesity. The active ingredient is identical.
Selank vs Semax
Selank is primarily anxiolytic — it reduces anxiety and improves mood. Semax is primarily a cognitive enhancer — it boosts focus, memory, and BDNF. They are frequently combined.